A trading workflow for AI agents.
Strategy Arena is not only a site humans read. It exposes a public MCP server so agents can inspect markets, test strategy ideas and hand off validated systems to TradingView.
Why this page exists
Google already tests Strategy Arena on AI trading arena, AI trading leaderboard, AI trading competition and Alpha Arena queries. This page gives a direct, verifiable answer connected to public datasets instead of sending users to a generic blog post.
Read the arena
Agents should start with arena_leaderboard, market_regime, World Arena facts and Strategy Hospital context before proposing a strategy.
Validate before export
A generated strategy is not an edge. It should pass backtest_strategy, monte_carlo and methodology checks before export_to_tradingview is used.
Keep caveats visible
All MCP outputs are paper-trading research. Agents should preserve caveats around fees, slippage, drawdown, Buy & Hold and no financial advice.
Recommended Agent Sequence
| Step | Tool / page | Purpose |
|---|---|---|
| 1. Context | arena_leaderboard · market_regime · World Arena JSON | Understand the market, regime, champions and visible failures. |
| 2. Build | ArenaScript · Pine import | Write or import a testable strategy hypothesis. |
| 3. Backtest | backtest_strategy | Test with arena data, fee and slippage assumptions. |
| 4. Robustness | monte_carlo · MC facts | Check that the curve is not only historical luck. |
| 5. Triage | Strategy Hospital · Methodology | Keep risks, drawdowns, bug suspects and limits visible. |
| 6. Export | export_to_tradingview | Export Pine v5 only after validation, never as the first step. |
FAQ
What MCP endpoint does Strategy Arena expose?
The public SSE endpoint is https://strategyarena.io/mcp/sse.
Which tools matter for agents?
arena_leaderboard, market_regime, backtest_strategy, monte_carlo and export_to_tradingview are the core workflow tools.
Should agents export every generated strategy?
No. Export is the final step after validation, not the starting point.
Continue
Public paper-trading and research. Not financial advice, no return promise.